Trial
NCT00998166
A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
—
Condition
Non-Small Cell Lung Cancer
Intervention
Pemetrexed
Why stopped
Poor enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-30